[1]李修元,杨 峰,敖素华.流感循证能力现状评估[J].医学信息,2021,34(19):37-40.[doi:10.3969/j.issn.1006-1959.2021.19.009]
 LI Xiu-yuan,YANG Feng,AO Su-hua.Evaluation of Evidence-based Ability of Influenza[J].Medical Information,2021,34(19):37-40.[doi:10.3969/j.issn.1006-1959.2021.19.009]
点击复制

流感循证能力现状评估()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年19期
页码:
37-40
栏目:
综述
出版日期:
2021-10-01

文章信息/Info

Title:
Evaluation of Evidence-based Ability of Influenza
文章编号:
1006-1959(2021)19-0037-04
作者:
李修元杨 峰敖素华
西南医科大学附属中医医院呼吸内科,四川 泸州 646000
Author(s):
LI Xiu-yuanYANG FengAO Su-hua
Department of Respiratory,Affiliated Hospital of Traditional Chinese Medicine,Southwest Medical University,Luzhou 646000,Sichuan,China
关键词:
流感循证能力退热时间
Keywords:
InfluenzaEvidence-based capacityFever resolution time
分类号:
R511.7
DOI:
10.3969/j.issn.1006-1959.2021.19.009
文献标志码:
A
摘要:
通过对流感文献的系统回顾来评估流感的证据,可以更好的选择流感治疗方案。在流行性传染病防控体系不断完善的时代背景下,对流感循证能力现状的评估更是十分重要。本研究以流感退热时间作为主要结局指标,从西药、中药、其他疗法以及针对儿童的流感退热研究等4个方面展开综述,以期为流感防治新策略的建立与筛选提供帮助。
Abstract:
Assessing the evidence for influenza through a systematic review of the influenza literature allows for better selection of influenza treatment options, and the assessment of the current state of evidence-based capacity for influenza is even more important in the context of an era of improving prevention and control systems for pandemic infectious diseases. In this study, influenza fever reduction time is used as the main outcome indicator, reviews four aspects including western medicine, traditional Chinese medicine, other therapies and influenza fever reduction studies for children, in order to provide help for the establishment and screening of new influenza prevention and control strategies

参考文献/References:

[1]Labella AM,Merel SE.Influenza[J].Med Clin North Am,2013,97(4):621-645.[2]孟璐,李婉,黄毅,等.发热需要退烧吗?[J/OL].医学争鸣,2021:1-8.[3]黄金峰,黄媛,李雪,等.流感患者早期血常规及C反应蛋白的特点与症状分析[J].军事医学,2019,43(8):612-615.[4]唐源,张光莉,罗斯颖,等.重庆医科大学附属儿童医院甲型流感病毒肺炎患儿617例临床特征及重症危险因素分析[J].中国实用儿科杂志,2019,34(12):1017-1021. [5]Li M,Han GC,Chen Y,et al.Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial[J].Braz J Med Biol Res,2020,54(2):e9542.[6]Pshenichnaya NY,Bulgakova VA,Lvov NI,et al.Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)[J].Ter Arkh,2019,91(3):56-63.[7]Haffizulla J,Hartman A,Hoppers M,et al.Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial[J].Lancet Infect Dis,2014,14(7):609-618.[8]Chen HD,Wang X,Yu SL,et al.Clinical Effectiveness of Intravenous Peramivir Compared With Oseltamivir in Patients With Severe Influenza A With Primary Viral Pneumonia: A Randomized Controlled Study[J].Open Forum Infect Dis,2020,8(1):ofaa562.[9]Langley JM,Aoki F,Ward BJ,et al.A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness[J].Vaccine,2011,29(10):1921-1928.[10]Nong Y,Lin JT,Sun XW,et al.Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial[J].National Medical Journal of China,2021,101(3):205-211.[11]Wang C,Cao B,Liu QQ,et al.Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial[J].Ann Intern Med,2011,155(4):217-225.[12]Wang L,Zhang RM,Liu GY,et al.Chinese herbs in treatment of influenza: a randomized, double-blind, placebo-controlled trial[J].Respir Med,2010,104(9):1362-1369.[13]李国勤,赵静,屠志涛,等.金花清感颗粒治疗流行性感冒风热犯肺证双盲随机对照研究[J].中国中西医结合杂志,2013,33(12):1631-1635.[14]练天生.加味银翘方治疗甲型H1N1流感病毒感染与奥司他韦等效性随机平行对照研究[J].实用中医内科杂志,2017,31(10):14-17.[15]胡亚丹.温灸刮痧疗法配合感冒退热合剂治疗乙型流感的疗效观察[J].中西医结合研究,2020,12(3):171-172.[16]张奕颖,陈欣.中药穴位贴敷对流感患者退热作用的临床观察[J].国医论坛,2020,35(2):25-27.[17]王静凛.大椎穴刺络拔罐治疗小儿流感发热疗效观察[J].实用中西医结合临床,2019,19(4):45-47.[18]张文青,罗文杰,奚小土,等.中药沐足治疗甲型H1N1流感发热16例疗效观察[J].新中医,2010,42(7):77.[19]Dawood FS,Jara J,Gonzalez R,et al.A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama[J].Antiviral Res,2016(133):85-94.[20]Baker J,Block SL,Matharu B,et al.Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2) [J].Pediatr Infect Dis J,2020,39(8):700-705.[21]Hirotsu N,Saisho Y,Hasegawa T,et al.Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan[J].Expert Rev Anti Infect Ther,2018,16(2):173-182.[22]Rotrosen E,Zaman K,Feser J,et al.Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial[J].Clin Infect Dis,2017,65(11):1914-1920.[23]邢轶维.小儿热速清颗粒治疗儿童甲型流感的临床效果观察[J].内蒙古中医药,2019,38(1):8-9.

相似文献/References:

[1]高 枫,阿不都热依木,樊旭成,等.2016~2017年乌鲁木齐市流感监测结果分析[J].医学信息,2018,31(19):134.[doi:10.3969/j.issn.1006-1959.2018.19.040]
 GAO Feng,Abdureyim,FAN Xu-cheng,et al.Analysis of Influenza Surveillance Results in Urumqi from 2016 to 2017[J].Medical Information,2018,31(19):134.[doi:10.3969/j.issn.1006-1959.2018.19.040]
[2]郑 梅,王志鹏,孙雅娜,等.2013~2018年天津市津南区0~14岁儿童季节性 甲型H1N1流感病原学监测分析[J].医学信息,2019,32(12):142.[doi:10.3969/j.issn.1006-1959.2019.11.046]
 ZHENG Mei,WANG Zhi-peng,SUN Ya-na,et al.Epidemiological Surveillance of Seasonal H1N1 Influenza in Children Aged 0-14 Years in Jinnan District of Tianjin from 2013 to 2018[J].Medical Information,2019,32(19):142.[doi:10.3969/j.issn.1006-1959.2019.11.046]
[3]荣 菊,邬 薇,张爱青.南京地区儿童门急诊季节性流感的分型和淋巴单核细胞含量比的特征分析[J].医学信息,2021,34(05):147.[doi:10.3969/j.issn.1006-1959.2021.05.042]
 RONG Ju,WU Wei,ZHANG Ai-qing.Analysis of Clinical Characteristics of Seasonal Influenza Type and Lymphatic Mononuclear Cell Content Ratio of Children in Outpatient and Emergency Department in Nanjing Area[J].Medical Information,2021,34(19):147.[doi:10.3969/j.issn.1006-1959.2021.05.042]
[4]侯攀锋,何文英.基于集中度和圆形分布法分析新疆某三甲医院流感发病季节性特征[J].医学信息,2021,34(20):151.[doi:10.3969/j.issn.1006-1959.2021.20.040]
 HOU Pan-feng,HE Wen-ying.Analysis of Seasonal Characteristics of Influenza in a Tertiary Hospital in XinjiangBased on Concentration and Circular Distribution[J].Medical Information,2021,34(19):151.[doi:10.3969/j.issn.1006-1959.2021.20.040]

更新日期/Last Update: 1900-01-01